Collectively, METTL3 drives tumorigenesis, cell invasion and chemotherapy resistance of CRC cells might via METTL3/SOX2/CCND1-MYC-POU5F1 axis (19). The gene discussed is METTL3; the disease is colorectal carcinoma.